{"transactions":[{"id":905779,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"officer":true,"officer_title":"EVP, RA and GA and PgM"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:01:12.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-004165","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004165/rdgdoc.xml","form_type":"4"}},{"id":2048438,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-23T23:36:39.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments."}],"balance_after":65000,"derivative":{"exercise_price":10.18,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924323002436/doc4.xml","form_type":"4"}},{"id":2048437,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-01-23T23:36:39.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":42250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":58635,"source":{"system":"sec-edgar","filing":"0000899243-23-002436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924323002436/doc4.xml","form_type":"4"}},{"id":2126881,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-03T00:36:36.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":1115,"price":12.4574,"value":13890.001,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.  These sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16385,"source":{"system":"sec-edgar","filing":"0000899243-22-034834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924322034834/doc4.xml","form_type":"4"}},{"id":2531639,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-29T23:28:17.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments."}],"balance_after":75000,"derivative":{"exercise_price":14,"expiration_date":"2031-10-27","underlying":"Common stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-21-042089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924321042089/doc4.xml","form_type":"4"}},{"id":2531638,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-29T23:28:17.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0000899243-21-042089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000089924321042089/doc4.xml","form_type":"4"}}]}